Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Plexian | PLEX | Mar 28, 2024 | 0.05 | +21.95 |
PMD Device Solutions | PMDS | Mar 28, 2024 | 9.60 | 0.00 |
PolarCool | POLAR | Mar 28, 2024 | 0.18 | +16.88 |
Polygiene | POLYG | Mar 28, 2024 | 7.67 | -0.26 |
Polymer Factory Sweden | POLYMER | Mar 28, 2024 | 0.72 | 0.00 |
Polyplank | POLY | Mar 28, 2024 | 0.05 | -7.61 |
PowerCell Sweden | PCELL | Mar 28, 2024 | 29.70 | -0.44 |
Prebona | PREBON | Mar 28, 2024 | 3.34 | 0.00 |
Precio Fishbone B | PRCOB | Mar 28, 2024 | 37.00 | +2.78 |
Precise Biometrics | PREC | Mar 28, 2024 | 1.11 | +1.46 |
Precomp Solutions B | PCOMB | Mar 28, 2024 | 0.97 | 0.00 |
Premium Snacks Nordic | SNX | Mar 28, 2024 | 8.25 | 0.00 |
Preservia Holding PREF | PHOLPREF | Mar 28, 2024 | 11.40 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | Mar 28, 2024 | 0.13 | 0.00 |
Preservia Hyresfastigheter PREF | PHYRPREF | Mar 28, 2024 | 42.00 | 0.00 |
Preservium Property | PRESRV | Mar 28, 2024 | 30.60 | 0.00 |
Prevas B | PREVB | Mar 28, 2024 | 122.60 | +0.99 |
Pricer B | PRICB | Mar 28, 2024 | 10.24 | +1.39 |
Proact IT Group | PACT | Mar 28, 2024 | 110.60 | +2.41 |
Probi | PROB | Mar 28, 2024 | 211.00 | +2.93 |
ProfilGruppen B | PROFB | Mar 28, 2024 | 132.00 | 0.00 |
Profoto Holding | PRFO | Mar 28, 2024 | 75.20 | -2.59 |
Projektengagemang Sweden B | PENGB | Mar 28, 2024 | 9.04 | +2.03 |
Prolight Diagnostics | PRLD | Mar 28, 2024 | 0.19 | -0.53 |
Promimic AB | PRO | Mar 28, 2024 | 30.80 | -1.60 |
ProstaLund | PLUN | Mar 28, 2024 | 1.06 | -7.79 |
Prostatype Genomics | PROGEN | Mar 28, 2024 | 0.06 | +12.73 |
Provide IT | PROVIT | Mar 28, 2024 | 1.96 | +3.16 |
Purefun | PURE | Mar 28, 2024 | 10.90 | -0.91 |
Q-Linea | QLINEA | Mar 28, 2024 | 2.14 | -0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.